Product Information
Registration Status: ActiveSIN14534P
NIMENRIX POWDER AND SOLVENT FOR SOLUTION FOR INJECTION is approved to be sold in Singapore with effective from 2014-03-04. It is marketed by PFIZER PTE LTD, with the registration number of SIN14534P.
This product contains Neisseria Meningitidis Group A Polysaccharide 5 micrograms,Neisseria Meningitidis Group C Polysaccharide 5 micrograms,Neisseria Meningitidis Group W-135 Polysaccharide 5 micrograms,Neisseria Meningitidis Group Y Polysaccharide 5 micrograms, and Tetanus Toxoid Carrier Protein ~44 micrograms in the form of INJECTION, POWDER, FOR SOLUTION. It is approved for INTRAMUSCULAR use.
This product is manufactured by Catalent Belgium S.A. (diluent in pre-filled syringe) in BELGIUM, andDelpharm Tours (diluent in ampoule) in FRANCE.
It is a Prescription Only Medicine that can only be obtained from a doctor or a dentist, or a pharmacist with a prescription from a Singapore-registered doctor or dentist.
Product Reference
Important Note: For generic product, the SPC/PIL provided may not be brand specific.
{{/items}} {{^items}}Source of information: Drugbank (External Link). Last updated on: 3rd July 18. *Trade Name used in the content below may not be the same as the HSA-registered product.
Source of information: Drugbank (External Link). Last updated on: 3rd July 18. *Trade Name used in the content below may not be the same as the HSA-registered product.
Source of information: Drugbank (External Link). Last updated on: 3rd July 18. *Trade Name used in the content below may not be the same as the HSA-registered product.
Source of information: Drugbank (External Link). Last updated on: 3rd July 18. *Trade Name used in the content below may not be the same as the HSA-registered product.
Source of information: Drugbank (External Link). Last updated on: 3rd July 18. *Trade Name used in the content below may not be the same as the HSA-registered product.